Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: Levetiracetam for Seizure Prevention After Brain Tumor Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of levetiracetam to prevent postoperative seizures after brain tumor surgery is listed, but recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keppra (levetiracetam)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Postoperative Seizures After Brain Tumor Surgery | Phase 3 | Status: NOT_YET_RECRUITING